Related Experiment Video

Updated: Sep 23, 2026

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
07:29

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Published on: October 12, 2017

Clinical impact of HIV-related lipodystrophy and metabolic abnormalities on cardiovascular disease

Georg M N Behrens1, Dirk Meyer-Olson, Matthias Stoll

  • 1Department of Clinical Immunology, Hannover Medical School, Hannover, Germany. Behrens@wehi.edu.au

AIDS (London, England)
|July 23, 2003
PubMed

Insights

Metabolic issues and fat changes in HIV patients on antiretroviral therapy can speed up coronary artery disease (CAD). Understanding these risks is crucial for managing heart health in this population.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Metabolic Disorders

Background:

  • HIV infection and antiretroviral therapy (ART) are linked to metabolic complications and abnormal fat distribution.
  • These changes may accelerate the development of coronary artery disease (CAD) in individuals with HIV.
  • A high prevalence of cardiovascular risk factors in HIV patients necessitates careful monitoring and management.

Purpose of the Study:

  • To summarize prevalent risk factors for coronary artery disease (CAD) in individuals with HIV receiving highly active antiretroviral therapy (HAART).
  • To focus on the clinical implications of metabolic abnormalities and HIV-related lipodystrophy on CAD.
  • To highlight the need for further research into cardiac event rates and clinical management strategies.

Main Methods:

  • Review of prevalent risk factors associated with HIV infection and HAART.
  • Focus on clinical implications of metabolic abnormalities.
  • Analysis of HIV-related lipodystrophy's impact on CAD.

Main Results:

  • Metabolic complications and altered fat distribution are significant concerns in HIV patients on HAART.
  • These factors contribute to an increased risk of accelerated coronary artery disease (CAD).
  • Non-invasive strategies for subclinical CAD detection in this population remain inconclusive.

Conclusions:

  • Metabolic abnormalities and lipodystrophy in HIV patients on HAART are strongly associated with accelerated CAD.
  • Further long-term studies are essential to determine cardiac event rates and guide clinical management.
  • Close monitoring of cardiovascular risk factors is critical for patients with HIV.

Related Concept Videos

Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Lipid-derived Compounds in the Human Body01:31

Lipid-derived Compounds in the Human Body

Fats and lipids are crucial components in the human body. Some lipid-derived compounds, such as fat-soluble vitamins, eicosanoids, lipoproteins, and glycolipids, also play unique roles to support various  biological processes .
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin, delayed...